Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...

Extremely low birth weight (ELBW) infants with moderate to large patent ductus arteriosus (PDA) may benefit from transcatheter PDA closure (TCPC) in the first four weeks of life, according to research ...

Celularity (CELU) announced the publication of its Phase 2 study titled “Human Placenta-Derived Cells, PDA-002, in Diabetic Foot Ulcer Patients ...

My wife's well-used Dell Axim X50v PDA is starting to get long in the tooth and because it runs the older Windows Mobile software it isn't compatable with the the latest version of UpToDate medical ...

Cyclooxygenase inhibitors (CI) are widely accepted treatment for hemodynamically significant persistant ductus arteriosus (HsPDA) of the preterm infant (PI) Failure of medical closure of PDA is ...

Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy, according to a study published in the February issue of CNS ...

First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound ...

The Parenteral Drug Association (PDA) proudly announces that it will be a supporting organization of the Johnson & Johnson Kilmer Conference on sterility assurance and sterilization in 2016. Johnson & ...

This is either a technological breakthrough or a sign that the medical profession is getting lazier by the minute: Aranz Medical’s SilhouetteMobile PDA was designed to diagnose how bad a wound is, and ...

Commentary--Medical sales reps know the scenario: It's a typical, busy day in the doctor's office, and—as is increasingly the case—there's a roadblock. The office nurse suggests that today is not a ...